0.131
price down icon5.21%   -0.0072
after-market Handel nachbörslich: .13 -0.001 -0.76%
loading
Schlusskurs vom Vortag:
$0.1382
Offen:
$0.1368
24-Stunden-Volumen:
5.52M
Relative Volume:
0.87
Marktkapitalisierung:
$128.37M
Einnahmen:
$25.19M
Nettoeinkommen (Verlust:
$-34.53M
KGV:
-3.6389
EPS:
-0.036
Netto-Cashflow:
$-20.62M
1W Leistung:
-10.82%
1M Leistung:
+5.22%
6M Leistung:
-9.41%
1J Leistung:
-18.38%
1-Tages-Spanne:
Value
$0.1301
$0.1379
1-Wochen-Bereich:
Value
$0.1301
$0.1533
52-Wochen-Spanne:
Value
$0.117
$0.1952

Zomedica Corp Stock (ZOM) Company Profile

Name
Firmenname
Zomedica Corp
Name
Telefon
734-369-2555
Name
Adresse
100 Phoenix Drive, Suite 190, Ann Arbor, MI
Name
Mitarbeiter
20
Name
Twitter
@zomedica
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
ZOM's Discussions on Twitter

Vergleichen Sie ZOM mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
ZOM
Zomedica Corp
0.131 128.37M 25.19M -34.53M -20.62M -0.036
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
163.32 73.68B 9.15B 2.43B 2.31B 5.32
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.10 41.15B 14.26B 1.55B 0 0.3383
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
12.95 41.06B 30.27B 1.93B 3.45B 0.6044
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.94 23.73B 16.77B -959.00M 1.37B -0.85
Drug Manufacturers - Specialty & Generic icon
NBIX
Neurocrine Biosciences Inc
140.90 14.27B 2.24B 385.90M 440.10M 3.73

Zomedica Corp Stock (ZOM) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-01-06 Eingeleitet Dawson James Buy

Zomedica Corp Aktie (ZOM) Neueste Nachrichten

pulisher
Jan 11, 2025

Zomedica (NYSEAMERICAN:ZOM) Stock Price Down 2.2% – Here’s What Happened - Defense World

Jan 11, 2025
pulisher
Jan 10, 2025

Geode Capital Management LLC Buys 321,395 Shares of Zomedica Corp. (NYSEAMERICAN:ZOM) - Defense World

Jan 10, 2025
pulisher
Jan 10, 2025

Zomedica (NYSEAMERICAN:ZOM) Stock Price Down 2.2% – Here’s Why - Defense World

Jan 10, 2025
pulisher
Jan 10, 2025

Zomedica (NYSEAMERICAN:ZOM) Stock Price Down 2.2%What's Next? - MarketBeat

Jan 10, 2025
pulisher
Jan 08, 2025

Zomedica enters license and supply agreement with Cresilon Inc. - DVM 360

Jan 08, 2025
pulisher
Jan 07, 2025

Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel(R) Hemostatic Gel in the Animal Health Market - AccessWire

Jan 07, 2025
pulisher
Jan 07, 2025

Zomedica Secures Exclusive U.S. Rights to Revolutionary Vetigel Bleeding Control Technology - StockTitan

Jan 07, 2025
pulisher
Dec 23, 2024

Zomedica Unveils New Canine Tests Offering Faster Diagnostics for Heart and Breeding Health - AOL

Dec 23, 2024
pulisher
Dec 23, 2024

Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone - AccessWire

Dec 23, 2024
pulisher
Dec 23, 2024

Zomedica Expands TRUFORMA Platform with Breakthrough 20-Minute Cardiac and Breeding Diagnostic Tests - StockTitan

Dec 23, 2024
pulisher
Dec 19, 2024

Zomedica appoints Scott Jordan as EVP, finance & CFO - MSN

Dec 19, 2024
pulisher
Dec 19, 2024

Zomedica (NYSEAMERICAN:ZOM) Trading Down 2.8% – Here’s Why - Defense World

Dec 19, 2024
pulisher
Dec 19, 2024

Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer - AccessWire

Dec 19, 2024
pulisher
Dec 19, 2024

Zomedica Strengthens Leadership: Industry Veteran with 30+ Years Experience Named New CFO - StockTitan

Dec 19, 2024
pulisher
Dec 19, 2024

Zomedica (NYSEAMERICAN:ZOM) Trading Down 2.8%Should You Sell? - MarketBeat

Dec 19, 2024
pulisher
Nov 27, 2024

Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024 - AccessWire

Nov 27, 2024
pulisher
Nov 27, 2024

Zomedica CEO to Present at NobleCon20 Conference, Investor Meetings Scheduled - StockTitan

Nov 27, 2024
pulisher
Nov 21, 2024

Zomedica secures new lease for headquarters expansion By Investing.com - Investing.com South Africa

Nov 21, 2024
pulisher
Nov 20, 2024

Zomedica secures new lease for headquarters expansion - Investing.com

Nov 20, 2024
pulisher
Nov 14, 2024

Noble Financial Predicts Zomedica FY2024 Earnings - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform - AccessWire

Nov 14, 2024
pulisher
Nov 14, 2024

Zomedica Launches 18-Minute Equine Insulin Test, Expands TRUFORMA Platform Capabilities | ZOM Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 12, 2024

Johnny D. Powers Purchases 100,000 Shares of Zomedica Corp. (NYSEAMERICAN:ZOM) Stock - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Zomedica (NYSEAMERICAN:ZOM) Stock Rating Upgraded by Noble Financial - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Noble Capital Markets Initiates Equity Research Coverage on Zomedica - WICZ

Nov 12, 2024
pulisher
Nov 12, 2024

Zomedica (ZOM) Launches Noble Capital Markets Coverage to Boost Market Visibility | ZOM Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 11, 2024

Zomedica initiated with an Outperform at Noble Capital - TipRanks

Nov 11, 2024
pulisher
Nov 09, 2024

Zomedica Corp. (AMEX:ZOM) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 09, 2024
pulisher
Nov 09, 2024

Zomedica Corp (ZOM) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... By GuruFocus - Investing.com Canada

Nov 09, 2024
pulisher
Nov 09, 2024

Earnings call: Zomedica reports record Q3 revenue, eyes future growth By Investing.com - Investing.com Australia

Nov 09, 2024
pulisher
Nov 08, 2024

Zomedica stock plunges to 52-week low of $0.12 amid market challenges By Investing.com - Investing.com South Africa

Nov 08, 2024
pulisher
Nov 08, 2024

Earnings call: Zomedica reports record Q3 revenue, eyes future growth - Investing.com

Nov 08, 2024
pulisher
Nov 08, 2024

Zomedica’s Revenue Up 10% Amid Global Expansion - TipRanks

Nov 08, 2024
pulisher
Nov 08, 2024

Zomedica stock plunges to 52-week low of $0.12 amid market challenges - Investing.com India

Nov 08, 2024
pulisher
Nov 08, 2024

Zomedica to Present at the Sidoti Micro Cap Conference November 14, 2024 - Herald Palladium

Nov 08, 2024
pulisher
Nov 08, 2024

Zomedica CEO to Present at Sidoti Micro Cap Conference, Showcases Pet Health Innovation | ZOM Stock News - StockTitan

Nov 08, 2024
pulisher
Nov 08, 2024

Zomedica Corp Posts Increased Revenue Amid Loss - TipRanks

Nov 08, 2024
pulisher
Nov 07, 2024

Zomedica Announces Third Quarter 2024 Financial Results: Revenue - WICZ

Nov 07, 2024
pulisher
Nov 07, 2024

Zomedica Announces Third Quarter 2024 Financial Results: Revenue Up 10% to $7 Million; 72% Gross Margin, and $78 Million in Liquidity to Support Growth - AccessWire

Nov 07, 2024
pulisher
Nov 07, 2024

Zomedica Q3 Revenue Jumps 10%, Diagnostics Surges 38% Despite Wider Losses | ZOM Stock News - StockTitan

Nov 07, 2024
pulisher
Oct 31, 2024

Zomedica stock plunges to 52-week low at $0.12 amid market challenges - Investing.com India

Oct 31, 2024
pulisher
Oct 24, 2024

ZOMZomedica Corp. Latest Stock News & Market Updates - StockTitan

Oct 24, 2024
pulisher
Oct 24, 2024

Zomedica Launches Ear Cytology Quick Scan Protocol for TRUVIEW(TM) Digital Microscope & Telepathology Platform - AccessWire

Oct 24, 2024
pulisher
Oct 23, 2024

Zomedica to Report Third Quarter 2024 Financial Results and Provide Business Update on November 7th at 4:30 p.m. ET - AccessWire

Oct 23, 2024
pulisher
Oct 23, 2024

Zomedica stock plunges to 52-week low at $0.12 amid market challenges By Investing.com - Investing.com South Africa

Oct 23, 2024
pulisher
Oct 15, 2024

Adversity is less terrifying than hope: Zomedica Corp (ZOM) - SETE News

Oct 15, 2024

Finanzdaten der Zomedica Corp-Aktie (ZOM)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$11.43
price down icon 1.04%
$95.88
price up icon 2.00%
$94.87
price up icon 14.91%
drug_manufacturers_specialty_generic RDY
$15.42
price down icon 2.47%
$11.67
price down icon 2.42%
$140.90
price up icon 1.58%
Kapitalisierung:     |  Volumen (24h):